Liefeng Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Minwen Xu (9 shared papers)Xiaoli Zhang (4 shared papers)Weiqiang Chen (1 shared paper)Dong‐Ming Su (5 shared papers)Xin Xie (3 shared papers)Weikan Wang (3 shared papers)Weiqiang Chen (2 shared papers)Yucai Wang (2 shared papers)
- Journals
- Cell Death and Disease (2 papers)The Journal of Immunology (2 papers)Oncotarget (2 papers)Journal of Medicinal Chemistry (1 paper)The FASEB Journal (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Liefeng Wang
26 papers receiving 619 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 161
- Biological Psychiatry 21
- Aging 13
- Neurology 47
- Molecular Biology 291
Countries citing papers authored by Liefeng Wang
This map shows the geographic impact of Liefeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liefeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liefeng Wang more than expected).
Fields of papers citing papers by Liefeng Wang
This network shows the impact of papers produced by Liefeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liefeng Wang. The network helps show where Liefeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liefeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 149 | |
| 2 | 2018 | 60 | |
| 3 | 2011 | 55 | |
| 4 | 2020 | 50 | |
| 5 | 2021 | 40 | |
| 6 | 2016 | 32 | |
| 7 | 2010 | 30 | |
| 8 | 2020 | 30 | |
| 9 | 2024 | 25 | |
| 10 | 2017 | 22 | |
| 11 | 2018 | 20 | |
| 12 | 2023 | 19 | |
| 13 | Seven novel variants expand the spectrum of RPE65-related Leber congenital amaurosis in the Chinese population. | 2019 | 15 |
| 14 | 2024 | 14 | |
| 15 | 2020 | 14 | |
| 16 | 2024 | 10 | |
| 17 | 2009 | 10 | |
| 18 | 2017 | 9 | |
| 19 | 2017 | 6 | |
| 20 | 2025 | 4 |
About Liefeng Wang
Liefeng Wang is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Cancer Research, having authored 26 papers that have together received 623 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Computational Drug Discovery Methods (2 papers), Congenital gastrointestinal and neural anomalies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Immune cells in cancer (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (161 citations), Biological Psychiatry (21 citations), Aging (13 citations), Neurology (47 citations) and Molecular Biology (291 citations). Liefeng Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Minwen Xu, Xiaoli Zhang, Weiqiang Chen, Dong‐Ming Su, Xin Xie, Weikan Wang, Weiqiang Chen, Yucai Wang, Linhui Ruan and Jie Lv. Their work appears in journals such as Cell Death and Disease, The Journal of Immunology, Oncotarget, Journal of Medicinal Chemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.